Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever

NCT ID: NCT01503294

Last Updated: 2014-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-29

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assessment and evaluation of body temperature is an important sign of health and disease. Inferior thermometry increases the risk of morbidity and mortality, and increases health care cost by delaying the diagnosis and treatment of fever-related disease. The gold standard for measuring core body temperature is the pulmonary artery thermistor (PAT). The measurement of the PAT requires the insertion of the invasive pulmonary artery catheter, a high risk procedure.

An innovative thermometry technology, the temporal artery thermometer (TAT), has been introduced into the clinical arena as a potential non-invasive proxy for the PAT. The TAT reduces the risk and cost of pulmonary artery catheter insertion by non-invasively measuring core blood temperature by measuring temperature over the skin of the temporal artery.

Research to demonstrate the precision and accuracy of the TAT in normothermic patients has been published, but little to no data is available in those with temperatures greater than 100.4oF. The purpose of this study is to measure the precision and accuracy of 2standard of care temperature methods: the thermistor from the PAT, considered the gold standard, and the TAT as measured in those patients with a PAT temperature greater than 100.4oF.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The results from previous studies agree that direct comparisons of the PAT and TAT are clinically comparable in the normal temperature range in adults. This was defined as a clinical significance difference of less than ±.5ºC (.9ºF. In the one study that assessed subjects with fevers (temperatures greater than 37.8oC (100.0oF) with some methodological criticism, compared the TAT to PAT in adults (n=15). There were poor correlations (r=0.3) among the adult measurements with a difference of 1.3+0.6o C. Eighty-nine percent of the TAT measurements were different than the PAT by more that ±.5ºC.

With only one study that focused in those who had a PAT outside the normal temperature range to evaluate accuracy and precision, there is a need for further research to assess the accuracy and precision of the TAT for detection of hyperthermia. A new onset of temperature equal to or above 100.4oF is defined as a fever and a temperature of 100.9oF is considered a reasonable trigger for a clinical assessment according to the Society of Critical Care Medicine in their fever guidelines for adults. Researchers synthesizing the literature on the TAT and other noninvasive temperature measurements, indicate that noninvasive temperature measurements are accurate for normal temperatures but may fail to detect hyperthermia and hypothermia, depending on the thermometer used. The authors concluded that the TAT is clinically comparable to the PAT in only the normal temperature range.

A repeated measures design will be used to describe the accuracy and precision of 2 temperature measurements, the PAT and the TAT. Study subjects will act as their own control in order to investigate the difference in PAT readings and the TAT readings in both the core and oral mode. The PAT will also be compared to the TAT reading taken by the clinical staff.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fever

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Temporal artery thermometer Pulmonary artery thermistor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Pulmonary artery catheter in place for a clinical indication,
2. fever \> 100.4oF

Exclusion Criteria

1. significant carotid or cerebrovascular disease,
2. PA catheter is not in proper position as confirmed by chest x-ray
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Diane L. Carroll

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Diane L Carroll, PhD, RN

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TAT-1

Identifier Type: -

Identifier Source: org_study_id